Cell Death Discovery

Journal Title：Cell Death Discovery

Cell Death Discovery is a multidisciplinary, international, online-only, open access journal, dedicated to publishing research at the intersection of medicine with biochemistry, pharmacology, immunology, cell biology and cell death, provided it is scientifically sound. The unrestricted access to research findings in Cell Death Discovery will foster a dynamic and highly productive dialogue between basic scientists and clinicians, as well as researchers in industry with a focus on cancer, neurobiology and inflammation research. As an official journal of the Cell Death Differentiation Association (ADMC), Cell Death Discovery will build upon the success of Cell Death & Differentiation and Cell Death & Disease in publishing important peer-reviewed original research, timely reviews and editorial commentary.

Cell Death Discovery is committed to increasing the reproducibility of research. To this end, in conjunction with its sister journals Cell Death & Differentiation and Cell Death & Disease, Cell Death Discovery provides a unique forum for scientists as well as clinicians and members of the pharmaceutical and biotechnical industry. It is committed to the rapid publication of high quality original papers that relate to these subjects, together with topical, usually solicited, reviews, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.

Cell Death Discovery 是一本多學科、國際化、在線、開放獲取的期刊，致力于發表醫學與生物化學、藥理學、免疫學、細胞生物學和細胞死亡交叉領域的研究，前提是這些研究具有科學性。Cell Death Discovery 中對研究結果的無限制訪問將促進基礎科學家和臨床醫生以及行業研究人員之間以癌癥、神經生物學和炎癥研究為重點的動態和高效對話。作為細胞死亡分化協會 (ADMC) 的官方期刊，Cell Death Discovery 將以 Cell Death & Differentiation 和 Cell Death & Disease 的成功為基礎，發表重要的同行評議原創研究、及時評論和編輯評論。

Cell Death Discovery 致力于提高研究的可重復性。為此，Cell Death Discovery 與其姊妹期刊 Cell Death & Differentiation 和 Cell Death & Disease 一起，為科學家、臨床醫生以及制藥和生物技術行業的成員提供了一個獨特的論壇。它致力于快速發表與這些主題相關的高質量原創論文，以及主題性、通常征求的評論、編??輯信件和對有爭議和科學信息問題的偶爾評論。

Cell Death Discovery創刊于2015年，由Springer Nature出版商出版，收稿方向涵蓋Biochemistry, Genetics and Molecular Biology - Cell Biology全領域，此刊是該細分領域中屬于非常不錯的SCI期刊，在行業細分領域中學術影響力較大，專業度認可很高，所以對原創文章要求創新性較高，如果您的文章質量很高，可以嘗試。平均審稿速度 9 Weeks ，影響因子指數6.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。